ChangSHTsaiYJChouHHWuTYHsiehCAChengST. Clinical predictors of long-term outcomes in patients with critical limb ischemia who have undergone endovascular therapy. Angiology. 2014;65(4):315–322.
DonBRKaysenG. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437.
4.
ChojkierM. Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol. 2005;39(4 suppl 2):S143–S146.
5.
QuinlanGJMartinGSEvansTW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41(6):1211–1219.
6.
VincentJLDuboisMJNavickisRJWilkesMM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319–334.
7.
MikhailidisDPGanotakisES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125–137.
8.
MikhailidisDPBarradasMAMarisAJeremyJYDandonaP. Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol. 1985;38(10):1166–1171.
9.
DaneshJCollinsRApplebyPPetoR. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA1998;279(18):1477–1482.
10.
GanotakisESVrentzosGEGaziIFPapadakisJAJagroopAParaskevasKI. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007;21(4):685–694.
11.
KrijgsmanBPapadakisJAGanotakisESMikhailidisDPHamiltonG. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol. 2002;21(1):44–52.
12.
Franch-ArcasG. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr. 2001;20(3):265–269.
13.
VincentJL. Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol. 2009;23(2):183–191.
